Tesla and Alphabet report quarterly earnings after the closing bell Wednesday, while Texas Instruments tumbles after issuing a disappointing profit forecast.

Understand 5 5kW 3 phase electric motor soft starter for air compressor information in Wenzhou Ziri Electric Technology Co.,Ltd company, and quickly obtain the latest quotation, select more quality ...

"Together, we now have the resources to progress through this next, important development phase, ensuring we secure the lozenges needed for our trial and critical inputs to our regulatory efforts." ...

Ultragenyx is developing setrusumab in pediatric and young adult patients across OI sub-types I, III and IV with two late-stage studies: the pivotal Phase 2/3 Orbit study and Phase 3 Cosmic study.

--Ultragenyx Pharmaceutical Inc. and Mereo BioPharma Group plc, today announced that the randomized, placebo-controlled Phase 3 portion of the Orbit study evaluating UX143 in pediatric and young ...

ARCHER II is a global, randomized, double-masked, sham-controlled Phase 3 trial that has enrolled more than 630 patients with advanced dry AMD/geographic atrophy (GA). Patients will be randomized 2:1 ...

a Tyr Pharma (ATYR) announced that the last patient has completed their last visit in the Company’s Phase 3 EFZO-FIT study of its lead therapeutic candidate, efzofitimod, in patients with ...

Yahoo Sports is on the road this summer hitting camps across the country, and we're rounding up the news, updates, position battles and more you need to know.

Data from Orbit and Cosmic studies expected around the end of the year NOVATO, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) and Mereo BioPharma Group plc ...